Search by Drug Name or NDC

NDC 70518-1844-01 Sildenafil 50 mg/1 Details

Sildenafil 50 mg/1

Sildenafil is a ORAL TABLET, FILM COATED in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by REMEDYREPACK INC.. The primary component is SILDENAFIL CITRATE.

MedlinePlus Drug Summary

Sildenafil (Viagra) is used to treat erectile dysfunction (impotence; inability to get or keep an erection) in men. Sildenafil (Revatio) is used to improve the ability to exercise in adults with pulmonary arterial hypertension (PAH; high blood pressure in the vessels carrying blood to the lungs, causing shortness of breath, dizziness, and tiredness). Children should not usually take sildenafil, but in some cases, a doctor may decide that sildenafil (Revatio) is the best medication to treat a child's condition. Sildenafil is in a class of medications called phosphodiesterase (PDE) inhibitors. Sildenafil treats erectile dysfunction by increasing blood flow to the penis during sexual stimulation. This increased blood flow can cause an erection. Sildenafil treats PAH by relaxing the blood vessels in the lungs to allow blood to flow easily. If you are taking sildenafil to treat erectile dysfunction, you should know that it does not cure erectile dysfunction or increase sexual desire. Sildenafil does not prevent pregnancy or the spread of sexually transmitted diseases such as human immunodeficiency virus (HIV).

Related Packages: 70518-1844-01
Last Updated: 02/19/2023
MedLinePlus Full Drug Details: Sildenafil

Product Information

NDC	70518-1844
Product ID	70518-1844_fb7fa9b0-4433-aab0-e053-6394a90ae10e
Associated GPIs
GCN Sequence Number	n/a
GCN Sequence Number Description	n/a
HIC3	n/a
HIC3 Description	n/a
GCN	n/a
HICL Sequence Number	n/a
HICL Sequence Number Description	n/a
Brand/Generic	n/a
Proprietary Name	Sildenafil
Proprietary Name Suffix	n/a
Non-Proprietary Name	Sildenafil
Product Type	HUMAN PRESCRIPTION DRUG
Dosage Form	TABLET, FILM COATED
Route	ORAL
Active Ingredient Strength	50
Active Ingredient Units	mg/1
Substance Name	SILDENAFIL CITRATE
Labeler Name	REMEDYREPACK INC.
Pharmaceutical Class	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]
DEA Schedule	n/a
Marketing Category	ANDA
Application Number	ANDA202659
Listing Certified Through	2024-12-31

Package

NDC 70518-1844-01 (70518184401)

Pricing Information	N/A
NDC Package Code	70518-1844-1
Billing NDC	70518184401
Package	30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (70518-1844-1)
Marketing Start Date	2022-12-12
NDC Exclude Flag	N